YTS109 cell
IIT2025030
Phase 1 mab active
Quick answer
YTS109 cell for Systemic Lupus Erythematosus (SLE) is a Phase 1 program (mab) at China SXT Pharmaceuticals with 4 ClinicalTrials.gov record(s).
Program details
- Company
- China SXT Pharmaceuticals
- Indication
- Systemic Lupus Erythematosus (SLE)
- Phase
- Phase 1
- Modality
- mab
- Status
- active